The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Toxicities and therapeutic effect of 5-fluorouracil controlled release implant on tumor-bearing rats
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, the acquired drug resistance, short half-life of 10–20 min, and harmful side effects on the bone marrow and gastrointestinal tract (GIT), remain among the limitations of its clinical use [9,10].”
From Novel Green Biosynthesis of 5-Fluorouracil Chromium Nanoparticles Using Harpullia pendula Extract for Treatment of Colorectal Cancer (2021) · cites this paper as [10]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
In vitro and in vivo release of ciprofloxacin from PLGA 50:50 implants
Ramchandani, M., & Robinson, D. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00113-2 · Cited by 195
Research works printed but not linked: 31
- Aboagye EO, Saleem A, Cunningham VJ, Osman S, Price PM. Extraction of 5-fluorouracil by tumor and liver: a noninvasive positron emission tomography study of patients with gastrointestinal cancer. Cancer Res 2001;61:4937-4941.
- Xiao HB, Cao WX, Yin HR, Lin YZ, Ye SH. Influence of L-methionine-deprived total parenteral nutrition with 5-fluorouracil on gastric cancer and host metabolism. World J Gastroenterol 2001;7:698-701. · DOI
- Liu LX, Zhang WH, Jiang HC, Zhu AL, Wu LF, Qi SY, Piao DX. Arterial chemotherapy of 5-fluorouracil and mitomycin C in the treatment of liver metastases of colorectal cancer. World J Gastroenterol 2002;8:663-667. · DOI
- Chen XX, Lai MD, Zhang YL, Huang Q. Less cytotoxicity to combination therapy of 5-fluorouracil and cisplatin than 5-fluorouracil alone in human colon cancer cell lines. World J Gastroenterol 2002;8:841-846. · DOI
- Cao S, Rustum YM. Synergistic antitumor activity of irinotecan in combination with 5-fluorouracil in rats bearing advanced colorectal cancer: role of drug sequence and dose. Cancer Res 2000;60:3717-3721.
- Yoshikawa R, Kusunoki M, Yanagi H, Noda M, Furuyama JI, Yamamura T, Hashimoto-Tamaoki T. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy. Cancer Res 2001;61:1029-1037.
- van Kuilenburg AB, Haasjes J, Richel DJ, Zoetekouw L, Van Lenthe H, De Abreu RA, Maring JG, Vreken P, van Gennip AH. Clinical implications of dihydropyrimidine dehydrogenase (DPD) deficiency in patients with severe 5-fluorouracil-associated toxicity: identification of new mutations in the DPD gene. Clin Cancer Res 2000;6:4705-4712.
- 10.1023/A:1012294617392 · DOI
- van Kuilenburg AB, Haasjes J, Richel DJ, Zoetekouw L, Van Lenthe H, De Abreu RA, Maring JG, Vreken P, van Gennip AH. Clinical implications of dihydropyrimidine dehydrogenase (DPD) deficiency in patients with severe 5-fluorouracil-associated toxicity: identification of new mutations in the DPD gene. Clin Cancer Res 2000;6:4705-4712.
- Fraile RJ, Baker LH, Buroker TR, Horwitz J, Vaitkevicius VK. Pharmacokinetics of 5-fluorouracil administered orally, by rapid intravenous and by slow infusion. Cancer Res 1980;40:2223-2228.
- Yi YM, Yang TY, Pan WM. Preparation and distribution of 5-fluorouracil (125)I sodium alginate-bovine serum albumin nanoparticles. World J Gastroenterol 1999;5:57-60. · DOI
- Kuan HY, Smith DE, Ensminger WD, Knol JA, DeRemer SJ, Yang Z, Stetson PL. Regional pharmacokinetics of 5-fluorouracil in dogs: role of the liver, gastrointestinal tract, and lungs. Cancer Res 1998;58:1688-1694.
- Schlemmer HP, Becker M, Bachert P, Dietz A, Rudat V, Vanselow B, Wollensack P, Zuna I, Knopp MV, Weidauer H. Alterations of intratumoral pharmacokinetics of 5-fluorouracil in head and neck carcinoma during simultaneous radiochemotherapy. Cancer Res 1999;59:2363-2369.
- 10.1016/S0169-409X(97)00036-7 · DOI
- 10.1016/S1056-8719(98)00027-6 · DOI · Paper page
- 10.1007/s101470200032 · DOI
- 10.1016/S0378-5173(99)00149-0 · DOI
- 10.1016/0304-3835(96)04337-6 · DOI
- Wang G, Tucker IG, Roberts MS, Hirst LW. In vitro and in vivo evaluation in rabbits of a controlled release 5-fluorouracil subconjunctival implant based on poly(D,L-lactide-co-glycolide). Pharm Res 1996;13:1059-1064. · DOI
- 10.1002/(SICI)1096-9098(199704)64:4<268::AID-JSO4>3.0.CO;2-7 · DOI
- 10.1016/0959-8049(95)00446-7 · DOI
- 10.1016/S0167-8140(98)00134-0 · DOI
- 10.1016/S0168-3659(02)00236-5 · DOI
- 10.1007/s002800050977 · DOI
- Tang WX, Cheng PY, Luo YP, Wang RX. Interaction between cisplatin, 5-fluorouracil and vincristine on human hepatoma cell line (7721). World J Gastroenterol 1998;4:418-420. · DOI
- Deng LY, Zhang YH, Xu P, Yang SM, Yuan XB. Expression of IL 1betaconverting enzyme in 5-FU induced apoptosis in esophageal carcinoma cells. World J Gastroenterol 1999;5:50-52. · DOI
- Jin J, Huang M, Wei HL, Liu GT. Mechanism of 5-fluorouracil required resistance in human hepatocellular carcinoma cell line Bel(7402). World J Gastroenterol 2002;8:1029-1034. · DOI
- 10.1097/00001813-199512000-00002 · DOI
- Harper E, Dang W, Lapidus RG, Garver RI. Enhanced efficacy of a novel controlled release paclitaxel formulation (PACLIMER delivery system) for local-regional therapy of lung cancer tumor nodules in mice. Clin Cancer Res 1999;5:4242-4248.
- 10.1023/A:1005704913330 · DOI
- 10.1089/cbr.1999.14.177 · DOI
Cited by
Sorted by citations
Saddik, M. S., Elsayed, M. M. A., Abdelkader, M. S. A., El-Mokhtar, M. A., Abdel-Aleem, J. A., Abu-Dief, A. M., Al-Hakkani, M. F., Farghaly, H. S., & Abou-Taleb, H. A. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13020226 · Cited by 89
Metadata
- Authors
- He, Y.-C.
- Venue
- World Journal of Gastroenterology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2003
- Volume
- 9
- Issue
- 8
- Pages
- 1795
- ISSN
- 1007-9327
- Cited by
- 28
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Toxicities and therapeutic effect of 5-fluorouracil controlled release implant on tumor-bearing rats. https://app.cochat.ai/papers/10.3748/wjg.v9.i8.1795
- The paper
- He, Y.-C. (2003). Toxicities and therapeutic effect of 5-fluorouracil controlled release implant on tumor-bearing rats. World Journal of Gastroenterology. https://doi.org/10.3748/wjg.v9.i8.1795